NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

$3.5 Million Bet On Aziyo Biologics? Check Out These 3 Penny Stocks Insiders Are Buying

Published 08/12/2022, 14:14
Updated 08/12/2022, 15:41
© Reuters.  $3.5 Million Bet On Aziyo Biologics? Check Out These 3 Penny Stocks Insiders Are Buying
TOON
-
ELUT
-
RDW
-
GNS
-

Benzinga - The Dow Jones closed almost flat on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Aziyo Biologics

  • The Trade: Aziyo Biologics, Inc. (NASDAQ: AZYO) Director Kevin Rakin bought a total of 735,000 shares at an average price of $4.75. To acquire these shares, it cost around $3.49 million.
  • What’s Happening: Aziyo Biologics recently announced pricing of an $11.2 million public offering of common stock.
  • What Aziyo Biologics Does: Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices.

Genius Brands International

  • The Trade: Genius Brands International, Inc. (NASDAQ: GNUS) Director Cynthia Turner-Graham acquired a total of 5,000 shares at an average price of $0.73. The insider spent around $3.67 thousand to buy those shares.
  • What’s Happening: The company, last month, posted a sharp rise in quarterly sales.
  • What Genius Brands International Does: Genius Brands International Inc is a kids media company. It is engaged in developing, producing, marketing, and licensing branded children's entertainment properties and consumer products for media and retail distribution.
Investor Sentiment Drops Further After S&P 500 Falls For Fifth Session

Don’t forget to check out our premarket coverage here .

Redwire

  • The Trade: Redwire Corporation (NYSE: RDW) Director John Bolton acquired a total of 43,839 shares at an average price of $2.01. To acquire these shares, it cost around $88.12 thousand.
  • What’s Happening: The company, last month, said revenue increased 14.0% to $37.2 million for the three months ended September 30, 2022.
  • What Redwire Does: Redwire Corp is engaged in mission-critical space solutions and reliable components for the next generation space economy, with IP for solar power generation and in-space 3D printing and manufacturing.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.